The Chimerix CMX001 Registry

Stopped early

Conditions studied: Outcomes, Survival Rates

In brief

The prospective observational study is to establish a registry database to evaluate the potential impact of prior treatment with CMX001 on the long-term incidence of specific events, such as outcomes, late CMV and other Double-stranded DNA virus associated events, s well as survival rates in subjects previously enrolled in selected clinical studies of CMX001. Each Registry participant will be followed for a period of approximately 3 years from their enrollment in the Registry.

Key facts

Study ID

NCT02167685

Run by

Jazz Pharmaceuticals

People needed

550

Starts

2014-01-01

Expected to finish

2019-05-10

Last updated by the study team

2019-05-17

Who can join

Age: 1 and older, up to 100. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Have previously completed study CMX001-301 through the Week 24 visit, or participated in another qualifying clinical study with CMX001.
• Willing and able to understand and provide written informed consent to participate in this observational study
• Willing and able to participate in all required study activities for the entire duration of the observational study (i.e., agreeable to being contacted at periodic intervals over the course of approximately 10 years following the completion of study CMX001-301 or other qualifying clinical study.

You may not qualify if…

• None

Where it is running

• St. Vincent Medical Center — Los Angeles, California, United States
• Children's Hospital of LA — Los Angeles, California, United States
• UCLA Medical Center — Los Angeles, California, United States
• Stanford University — Palo Alto, California, United States
• Childrens Hospital of Colorado — Aurora, Colorado, United States
• University of Colorado Denver — Aurora, Colorado, United States
• University of Colorado Hospital/Health Science Center — Aurora, Colorado, United States
• Yale University — New Haven, Connecticut, United States
• Children's National Medical Center — Washington D.C., District of Columbia, United States
• University of Miami — Miami, Florida, United States
• Emory University — Atlanta, Georgia, United States
• Winship Cancer Institute Emory University — Atlanta, Georgia, United States
• Northside Hospital — Atlanta, Georgia, United States
• Northwestern University School of Medicine — Chicago, Illinois, United States
• University of Chicago — Chicago, Illinois, United States
• University of Iowa Hospitals and Clinics — Iowa City, Iowa, United States
• Children's Hospital of New Orleans — New Orleans, Louisiana, United States
• Johns Hopkins University — Baltimore, Maryland, United States
• Brigham and Women's Hospital/Dana Farber Cancer Institute — Boston, Massachusetts, United States
• University of Michigan Health System — Ann Arbor, Michigan, United States
• Harper University Hospital — Detroit, Michigan, United States
• Henry Ford Hospital — Detroit, Michigan, United States
• University of Minnesota — Minneapolis, Minnesota, United States
• Children Mercy Hospital and Clinics — Kansas City, Missouri, United States
• University of California San Diego — La Jolla, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.